ipca laboratories uk limited Company Information
Company Number
04951981
Next Accounts
Dec 2025
Shareholders
ipca laboratories limited
ipca laboratories ltd
Group Structure
View All
Industry
Manufacture of pharmaceutical preparations
Registered Address
units 97-98 silverbriar, sunderland enterprise park east, sunderland, SR5 2TQ
Website
www.ipca.comipca laboratories uk limited Estimated Valuation
Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £12.7m based on a Turnover of £11.8m and 1.08x industry multiple (adjusted for size and gross margin).
ipca laboratories uk limited Estimated Valuation
Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £2m based on an EBITDA of £453.5k and a 4.47x industry multiple (adjusted for size and gross margin).
ipca laboratories uk limited Estimated Valuation
Pomanda estimates the enterprise value of IPCA LABORATORIES UK LIMITED at £17.6m based on Net Assets of £8.5m and 2.07x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ipca Laboratories Uk Limited Overview
Ipca Laboratories Uk Limited is a live company located in sunderland, SR5 2TQ with a Companies House number of 04951981. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in November 2003, it's largest shareholder is ipca laboratories limited with a 68.6% stake. Ipca Laboratories Uk Limited is a mature, mid sized company, Pomanda has estimated its turnover at £11.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ipca Laboratories Uk Limited Health Check
Pomanda's financial health check has awarded Ipca Laboratories Uk Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
6 Weak
Size
annual sales of £11.8m, make it smaller than the average company (£38.3m)
£11.8m - Ipca Laboratories Uk Limited
£38.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (4.8%)
5% - Ipca Laboratories Uk Limited
4.8% - Industry AVG
Production
with a gross margin of 10.2%, this company has a higher cost of product (30.9%)
10.2% - Ipca Laboratories Uk Limited
30.9% - Industry AVG
Profitability
an operating margin of 3.8% make it less profitable than the average company (7.7%)
3.8% - Ipca Laboratories Uk Limited
7.7% - Industry AVG
Employees
with 6 employees, this is below the industry average (93)
6 - Ipca Laboratories Uk Limited
93 - Industry AVG
Pay Structure
on an average salary of £63k, the company has an equivalent pay structure (£65.3k)
£63k - Ipca Laboratories Uk Limited
£65.3k - Industry AVG
Efficiency
resulting in sales per employee of £2m, this is more efficient (£386.2k)
£2m - Ipca Laboratories Uk Limited
£386.2k - Industry AVG
Debtor Days
it gets paid by customers after 102 days, this is later than average (50 days)
102 days - Ipca Laboratories Uk Limited
50 days - Industry AVG
Creditor Days
its suppliers are paid after 175 days, this is slower than average (34 days)
175 days - Ipca Laboratories Uk Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 170 days, this is more than average (117 days)
170 days - Ipca Laboratories Uk Limited
117 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is average cash available to meet short term requirements (8 weeks)
9 weeks - Ipca Laboratories Uk Limited
8 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 40.6%, this is a similar level of debt than the average (45%)
40.6% - Ipca Laboratories Uk Limited
45% - Industry AVG
IPCA LABORATORIES UK LIMITED financials
Ipca Laboratories Uk Limited's latest turnover from March 2024 is £11.8 million and the company has net assets of £8.5 million. According to their latest financial statements, Ipca Laboratories Uk Limited has 6 employees and maintains cash reserves of £1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 11,807,452 | 7,015,521 | 14,857,936 | 10,177,395 | |||||||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | |||||||||||
Cost Of Sales | 10,608,809 | 6,870,516 | 8,044,117 | 4,556,011 | |||||||||||
Gross Profit | 1,198,643 | 145,005 | 6,813,819 | 5,621,384 | |||||||||||
Admin Expenses | 750,876 | 736,018 | 4,040,073 | 3,481,002 | |||||||||||
Operating Profit | 447,767 | -591,013 | 2,773,746 | 2,140,382 | |||||||||||
Interest Payable | 0 | 0 | 0 | 8 | |||||||||||
Interest Receivable | 0 | 0 | 1,476 | 217 | |||||||||||
Pre-Tax Profit | 1,447,767 | -91,013 | 2,775,222 | 2,140,591 | |||||||||||
Tax | 0 | 0 | -567,802 | -431,546 | |||||||||||
Profit After Tax | 1,447,767 | -91,013 | 2,207,420 | 1,709,045 | |||||||||||
Dividends Paid | 0 | 0 | 0 | 0 | |||||||||||
Retained Profit | 1,447,767 | -91,013 | 2,207,420 | 1,709,045 | |||||||||||
Employee Costs | 378,000 | 336,244 | 3,779,834 | 3,001,059 | |||||||||||
Number Of Employees | 6 | 6 | 92 | 72 | 3 | 3 | |||||||||
EBITDA* | 453,459 | -590,544 | 3,501,644 | 2,600,091 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 22,855 | 1,405 | 4,013,687 | 2,374,964 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
Intangible Assets | 0 | 0 | 0 | 0 | 2 | 228,561 | 457,121 | 685,681 | 917,240 | 1,142,859 | 159,326 | 261,452 | 371,773 | 219,625 | 59,859 |
Investments & Other | 4,892,751 | 4,892,751 | 720,935 | 720,935 | 4,892,751 | 4,892,751 | 4,892,751 | 4,892,751 | 4,892,751 | 4,893,775 | 4,893,775 | 4,893,775 | 3,863,955 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 4,915,606 | 4,894,156 | 4,734,622 | 3,095,899 | 4,892,753 | 5,121,312 | 5,349,872 | 5,578,432 | 5,809,991 | 6,036,634 | 5,053,101 | 5,155,227 | 4,235,730 | 219,627 | 59,861 |
Stock & work in progress | 4,947,208 | 2,411,325 | 1,544,481 | 890,340 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 3,319,756 | 2,374,165 | 3,399,967 | 1,717,367 | 0 | 0 | 0 | 4,000 | 48,000 | 288,000 | 391,635 | 478,621 | 228,935 | 37,476 | 47,825 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 44,236 | 522,424 | 226,122 | 188,875 | 5,304 | 1,945 | 1,939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 1,043,130 | 147,852 | 2,006,589 | 3,334,001 | 12,159 | 18,875 | 18,022 | 23,879 | 11,758 | 24,421 | 10,711 | 11,700 | 74,059 | 63,019 | 87,793 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,029,820 | 0 | 0 |
total current assets | 9,354,330 | 5,455,766 | 7,177,159 | 6,130,583 | 17,463 | 20,820 | 19,961 | 27,879 | 59,758 | 312,421 | 402,346 | 490,321 | 1,332,814 | 100,495 | 135,618 |
total assets | 14,269,936 | 10,349,922 | 11,911,781 | 9,226,482 | 4,910,216 | 5,142,132 | 5,369,833 | 5,606,311 | 5,869,749 | 6,349,055 | 5,455,447 | 5,645,548 | 5,568,544 | 320,122 | 195,479 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 5,092,902 | 2,989,606 | 1,302,860 | 1,133,768 | 31,824 | 0 | 0 | 0 | 0 | 758,663 | 2,500 | 4,165 | 58,813 | 26,374 | 13,516 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 942,824 | 934,667 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 693,334 | 324,383 | 927,049 | 706,670 | 8,352 | 4,256 | 2,700 | 26,188 | 49,892 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 5,786,236 | 3,313,989 | 2,229,909 | 1,840,438 | 40,176 | 4,256 | 2,700 | 969,012 | 984,559 | 758,663 | 2,500 | 4,165 | 58,813 | 26,374 | 13,516 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 449,984 | 4,000,000 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,145,891 | 5,156,011 | 5,227,801 | 5,062,801 | 0 | 0 |
provisions | 0 | 0 | 411,127 | 322,719 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 411,127 | 322,719 | 0 | 0 | 0 | 0 | 449,984 | 5,145,891 | 5,156,011 | 5,227,801 | 5,062,801 | 0 | 0 |
total liabilities | 5,786,236 | 3,313,989 | 2,641,036 | 2,163,157 | 40,176 | 4,256 | 2,700 | 969,012 | 1,434,543 | 5,904,554 | 5,158,511 | 5,231,966 | 5,121,614 | 26,374 | 13,516 |
net assets | 8,483,700 | 7,035,933 | 9,270,745 | 7,063,325 | 4,870,040 | 5,137,876 | 5,367,133 | 4,637,299 | 4,435,206 | 444,501 | 296,936 | 413,582 | 446,930 | 293,748 | 181,963 |
total shareholders funds | 8,483,700 | 7,035,933 | 9,270,745 | 7,063,325 | 4,870,040 | 5,137,876 | 5,367,133 | 4,637,299 | 4,435,206 | 444,501 | 296,936 | 413,582 | 446,930 | 293,748 | 181,963 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 447,767 | -591,013 | 2,773,746 | 2,140,382 | |||||||||||
Depreciation | 5,692 | 469 | 727,898 | 459,709 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,110 |
Amortisation | 0 | 0 | 0 | 0 | 228,559 | 228,560 | 228,560 | 231,559 | 225,619 | 159,267 | 102,126 | 110,321 | 118,848 | 79,870 | 42,187 |
Tax | 0 | 0 | -567,802 | -431,546 | |||||||||||
Stock | 2,535,883 | 866,844 | 654,141 | 890,340 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 467,403 | -729,500 | 1,719,847 | 1,900,938 | 3,359 | 6 | -2,061 | -44,000 | -240,000 | -103,635 | -86,986 | 249,686 | 191,459 | -10,349 | 47,825 |
Creditors | 2,103,296 | 1,686,746 | 169,092 | 1,101,944 | 31,824 | 0 | 0 | 0 | -758,663 | 756,163 | -1,665 | -54,648 | 32,439 | 12,858 | 13,516 |
Accruals and Deferred Income | 368,951 | -602,666 | 220,379 | 698,318 | 4,096 | 1,556 | -23,488 | -23,704 | 49,892 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | -411,127 | 88,408 | 322,719 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -77,580 | -54,935 | 1,037,733 | 1,500,248 | |||||||||||
Investing Activities | |||||||||||||||
capital expenditure | 0 | 0 | 0 | 0 | |||||||||||
Change in Investments | 0 | 4,171,816 | 0 | -4,171,816 | 0 | 0 | 0 | 0 | -1,024 | 0 | 0 | 1,029,820 | 3,863,955 | 0 | 0 |
cash flow from investments | 0 | -4,171,816 | 0 | 4,171,816 | |||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | -942,824 | 8,157 | 934,667 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -449,984 | -3,550,016 | 4,000,000 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,145,891 | -4,010,120 | -71,790 | 165,000 | 5,062,801 | 0 | 0 |
share issue | |||||||||||||||
interest | 0 | 0 | 1,476 | 209 | |||||||||||
cash flow from financing | 0 | -2,143,799 | 1,476 | 484,449 | |||||||||||
cash and cash equivalents | |||||||||||||||
cash | 895,278 | -1,858,737 | -1,327,412 | 3,321,842 | -6,716 | 853 | -5,857 | 12,121 | -12,663 | 13,710 | -989 | -62,359 | 11,040 | -24,774 | 87,793 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 895,278 | -1,858,737 | -1,327,412 | 3,321,842 | -6,716 | 853 | -5,857 | 12,121 | -12,663 | 13,710 | -989 | -62,359 | 11,040 | -24,774 | 87,793 |
ipca laboratories uk limited Credit Report and Business Information
Ipca Laboratories Uk Limited Competitor Analysis
Perform a competitor analysis for ipca laboratories uk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in SR5 area or any other competitors across 12 key performance metrics.
ipca laboratories uk limited Ownership
IPCA LABORATORIES UK LIMITED group structure
Ipca Laboratories Uk Limited has no subsidiary companies.
Ultimate parent company
IPCA LABORATORIES LTD
#0036185
1 parent
IPCA LABORATORIES UK LIMITED
04951981
ipca laboratories uk limited directors
Ipca Laboratories Uk Limited currently has 2 directors. The longest serving directors include Dr Derek Londesbrough (Aug 2017) and Mr Manish Jain (Aug 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Derek Londesbrough | 54 years | Aug 2017 | - | Director | |
Mr Manish Jain | 50 years | Aug 2017 | - | Director |
P&L
March 2024turnover
11.8m
+68%
operating profit
447.8k
-176%
gross margin
10.2%
+391.15%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
8.5m
+0.21%
total assets
14.3m
+0.38%
cash
1m
+6.06%
net assets
Total assets minus all liabilities
ipca laboratories uk limited company details
company number
04951981
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
November 2003
age
22
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
LEESING MARRISON LEE LIMITED
address
units 97-98 silverbriar, sunderland enterprise park east, sunderland, SR5 2TQ
Bank
-
Legal Advisor
-
ipca laboratories uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ipca laboratories uk limited.
ipca laboratories uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for IPCA LABORATORIES UK LIMITED. This can take several minutes, an email will notify you when this has completed.
ipca laboratories uk limited Companies House Filings - See Documents
date | description | view/download |
---|